taxonomy (1)
protein (2)
source (2)
structure (12)
composition (21)
disease (1)
reference (3)
site (2)
peptide (1)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- BTI-Tn-5B1-4 (CVCL_C190)
- HEK293 (CVCL_0045)
Source
- N-Linked / High-Mannose / Structure 2812
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / High-Mannose / Structure 314
- N-Linked / High-Mannose / Structure 2636
- N-Linked / High-Mannose / Structure 10029
- N-Linked / Hybrid / Structure 10027
- N-Linked / Hybrid / Structure 1713
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Pauci-Mannose / Structure 10068
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ GlcNAc"
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-3)][Fuc(a1-6)]GlcNAc
- N-Linked / Pauci-Mannose / Structure 10067
Reported structure
- Hex:2 HexNAc:2 (avg mass : 748.6901 )
- Hex:2 HexNAc:2 dHex:1 (avg mass : 894.8331 )
- Hex:3 HexNAc:2 (avg mass : 910.8325 )
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:3 HexNAc:2 dHex:2 (avg mass : 1203.1185 )
- Hex:3 HexNAc:3 (avg mass : 1114.0275 )
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:3 dHex:2 (avg mass : 1406.3135 )
- Hex:4 HexNAc:3 (avg mass : 1276.1699 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
- Hex:6 HexNAc:2 (avg mass : 1397.2597 )
- Hex:6 HexNAc:3 (avg mass : 1600.4547 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:3 (avg mass : 1762.5971 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:10 HexNAc:2 (avg mass : 2045.8293 )
Composition
- COVID-19 (DOID:0080600)
Disease
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Reviewed
- Identification of 22 N-glycosites on spike glycoprotein of SARS-CoV-2 and accessible surface glycopeptide motifs: Implications for vaccination and antibody therapeutics (2020 - Dapeng Zhou, Xiaoxu Tian, Ruibing Qi, Chao Peng, Wen Zhang) / Status : Reviewed
Reference
-
- N-Linked / High-Mannose
(avg mass : 1235.1173)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- N-Linked / High-Mannose
(avg mass : 1397.2597)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- N-Linked / High-Mannose
(avg mass : 1559.4021)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- N-Linked / High-Mannose
(avg mass : 1721.5445)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- N-Linked / High-Mannose
(avg mass : 1883.6869)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- N-Linked / Hybrid
(avg mass : 1276.1699)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- N-Linked / Hybrid
(avg mass : 1438.3123)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- N-Linked / Pauci-Mannose
(avg mass : 910.8325)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- N-Linked / Pauci-Mannose
(avg mass : 1056.9755)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- N-Linked / Pauci-Mannose
(avg mass : 1114.0275)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- N-Linked / Pauci-Mannose
(avg mass : 1203.1185)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- N-Linked / Pauci-Mannose
(avg mass : 1260.1705)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:2 HexNAc:2 / N-Linked
(avg mass : 748.6901)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:2 HexNAc:2 dHex:1 / N-Linked
(avg mass : 894.8331)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:3 HexNAc:2 / N-Linked
(avg mass : 910.8325)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:3 HexNAc:2 dHex:1 / N-Linked
(avg mass : 1056.9755)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / Pauci-Mannose / Structure 10068
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:3 HexNAc:3 / N-Linked
(avg mass : 1114.0275)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / Pauci-Mannose / Man(a1-3)[Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ GlcNAc"
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:5 HexNAc:2 / N-Linked
(avg mass : 1235.1173)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / High-Mannose / Structure 2812
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:3 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1260.1705)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / Pauci-Mannose / Structure 10067
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:4 HexNAc:3 / N-Linked
(avg mass : 1276.1699)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / Hybrid / Structure 10027
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / High-Mannose / Man(a1-3)[Man(a1-6)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:3 HexNAc:3 dHex:2 / N-Linked
(avg mass : 1406.3135)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:4 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1422.3129)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:5 HexNAc:3 / N-Linked
(avg mass : 1438.3123)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / Hybrid / Structure 1713
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / High-Mannose / Structure 314
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:5 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1584.4553)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:6 HexNAc:3 / N-Linked
(avg mass : 1600.4547)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / High-Mannose / Structure 2636
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:7 HexNAc:3 / N-Linked
(avg mass : 1762.5971)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:4 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1828.7029)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
- BTI-Tn-5B1-4 (CVCL_C190)
- N-Linked / High-Mannose / Structure 10029
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (BTI-Tn-5B1-4) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- NFTTAPAICHDGK (13aa)
-
- Hex:10 HexNAc:2 / N-Linked
(avg mass : 2045.8293)
- BTI-Tn-5B1-4 (CVCL_C190)
- COVID-19 (DOID:0080600)
Source
Suggested structure
Disease
- Hex:10 HexNAc:2 / N-Linked
(avg mass : 2045.8293)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:9 HexNAc:2 / N-Linked
(avg mass : 1883.6869)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:5 dHex:1 / N-Linked
(avg mass : 1828.7029)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:3 / N-Linked
(avg mass : 1762.5971)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:8 HexNAc:2 / N-Linked
(avg mass : 1721.5445)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:3 / N-Linked
(avg mass : 1600.4547)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1584.4553)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:2 / N-Linked
(avg mass : 1559.4021)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:3 / N-Linked
(avg mass : 1438.3123)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1422.3129)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:3 dHex:2 / N-Linked
(avg mass : 1406.3135)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:6 HexNAc:2 / N-Linked
(avg mass : 1397.2597)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:4 HexNAc:3 / N-Linked
(avg mass : 1276.1699)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:3 dHex:1 / N-Linked
(avg mass : 1260.1705)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:5 HexNAc:2 / N-Linked
(avg mass : 1235.1173)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:3 / N-Linked
(avg mass : 1114.0275)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:2 dHex:1 / N-Linked
(avg mass : 1056.9755)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:3 HexNAc:2 / N-Linked
(avg mass : 910.8325)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:2 HexNAc:2 dHex:1 / N-Linked
(avg mass : 894.8331)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
- Hex:2 HexNAc:2 / N-Linked
(avg mass : 748.6901)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Pauci-Mannose
(avg mass : 1260.1705)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Pauci-Mannose
(avg mass : 1203.1185)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Pauci-Mannose
(avg mass : 1114.0275)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Pauci-Mannose
(avg mass : 1056.9755)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Pauci-Mannose
(avg mass : 910.8325)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Hybrid
(avg mass : 1438.3123)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Hybrid
(avg mass : 1276.1699)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / High-Mannose
(avg mass : 1883.6869)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / High-Mannose
(avg mass : 1721.5445)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / High-Mannose
(avg mass : 1559.4021)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / High-Mannose
(avg mass : 1397.2597)
Source
Disease
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / High-Mannose
(avg mass : 1235.1173)
